期刊文献+

组织病理学同行评议的GLP要求及关注点探讨 被引量:6

Discussion on GLP Requirements and Considerations in Peer Review of Histopathology
下载PDF
导出
摘要 目的:探讨组织病理学同行评议的GLP要求及关注点。方法:简要介绍药物非临床安全性评价领域组织病理学同行评议的指导原则、目的、GLP要求、GLP符合性要求、种类、地点、病理工作组、同行评议病理学家和专题病理学家的职责、动物数量的选择、建议归档文件、同行评议声明以及使用数字扫描全切片图像进行同行评议等内容。结果:组织病理学同行评议可核实并提高病理诊断和病理解释的准确性、一致性及完整性,提高病理报告的质量;同时,可作为毒性病理学家继续教育的重要组成部分。结论:本文探讨组织病理学同行评议的GLP要求及关注点,以期为我国药物非临床安全性评价领域更好地开展符合GLP的组织病理学同行评议提供一些参考。 Objective: To discuss GLP requirements and considerations in peer review of histopathology. Methods: This paper gave a brief introduction to the good laboratory practice (GLP) requirements and considerations in peer review of histopathology in nonclinical safety evaluation of drugs, including guidelines for peer review, purpose of peer review, GLP requirements of peer review, GLP compliant requirements of peer review, types of peer review, site of peer review, pathology working groups (PWGs), responsibilities of peer review pathologists and study pathologists, animal numbers to be reviewed, documents suggested to be archived , peer review statement, as well as utilizing whole slide images (WSIs) for peer review. Results: Peer review of histopathology can verify and improve the accuracy, consistency and completeness of pathology diagnoses and interpretation, improve the quality of the pathology report and serve as an important source of continuingeducation of toxicologic pathologists. Conclusion: ~e GLP requirements and considerations for peer review of histopathology were discussed with the aim to provide some references for better complying with GLP peer review of histopathology in nonclinical safety evaluation of ~gs in China,
作者 吕建军 霍桂桃 林志 屈哲 杨艳伟 张頔 霍艳 耿兴超 王雪 李波 Lv Jianjun;Huo Guitao;Lin Zhi;Qu Zhe;Yang Yanwei;Zhang Di;Huo Yan;Geng Xingchao;Wang Xue;Li Bo(Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China;National Institutes for Food and Drug Control, Beijing 100050, China)
出处 《中国药事》 CAS 2018年第4期485-493,共9页 Chinese Pharmaceutical Affairs
基金 十二五国家科技重大专项课题"符合中药特点的有毒中药安评关键技术"(编号2015ZX09501004-002) 十二五国家科技重大专项课题"生物大分子药物特殊评价关键技术研究"(编号2015ZX09501007-004)
关键词 良好实验室规范 毒性病理学 组织病理学 同行评议 指导原则 病理工作组 good laboratory practice tOxicologic pathology bistopathology peer review guidance pathologyworking groups
  • 相关文献

参考文献3

二级参考文献43

  • 1中国国家认证认可监督管理委员会.RB/T193-2015良好实验室规范在组织病理学同行评议中的应用指南[M].北京:中国标准出版社,2016:4.
  • 2Crissman JW,Goodman DG,Hildebrandt PK,et al.Best Practices Guideline:Toxicologic Histopathology[J].Toxicol Pathol,2004,32(1):126-131.
  • 3Morton D,Sellers R,Barale-thomas E,et al.zhgysh CHINESE PHARMACEUTICAL AFFAIRS Recommendations for Pathology Peer Review[J].Toxicol Pathol,2010,38:1118-1127.
  • 4The society of Toxicologic Pathologists.Peer Review in Toxicologic Pathology:Some Recommendations[J].Toxicol Pathol,1991,19(3):290-292.
  • 5Peters TS.Pathology Peer Review-a Concept for Consideration[J].Toxicol Pathol,1996,24(5):654-656.
  • 6Mann PC.Pathology Peer Review from the Perspective of an External Peer Review Pathologist[J].Toxicol Pathol,1996,24(5):650-653.
  • 7Organisation for Economic Cooperation and Development (OECD).Guidance Document 116 on the Conduct and Design of Chronic Toxicity and Carcinogenicity Studies,Supporting Test Guidelines 451,452 and 453:Second Edition,OECD Series on Testing and Assessment,No.116[EB/OL].(2012-04-13)[2016-08-10].http://www.oecd-ilibrary.org/content/book/9789264221475-en.
  • 8Mann PC and Hardisty JH.Pathology working groups[J].Toxicol Pathol,2014,42(1):283-284.
  • 9Organisation for Economic Cooperation and Development (OECD).OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring:No.16,Advisory Document of the Working Group on Good Laboratory Practice-Guidance on the GLP Requirements for Peer Review of Histopathology[EB/OL].(2014-12-15)[2016-08-10].http://www.oecd-ilibrary.org/content/book/9789264228306-en.
  • 10Fikes JD,Patrick DJ,Francke S,et al.Scientific and Regulatory Policy Committee Review:Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology[J].Toxicol Pathol,2015,43(7):907-914.

共引文献22

同被引文献10

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部